# Agent Handoff — 2026-07-26 (P2B Approver Identity Reconciliation)

## Disposition

- Tranche: `P2B-APPROVER-IDENTITY-RECONCILIATION`
- Control-chain phase: `WORK_ORDER`, approved; C2 pre-BUILD continuity
- Risk: R2 — changes the load-bearing approval control and requires live
  provider-backed governance evidence
- BUILD status: **NOT STARTED**
- Active implementation owner after C2/G6: Claude as `IMPLEMENTATION_WORKER`
- Independent reviewer and commit steward: Codex

## Authorization receipts

- Original C1:
  `f98f29e145fa002be070e9d44520d20f0f82dcb3`, exactly the ADR, SPEC and
  WORK_ORDER; retained unchanged.
- Authorization review revision 1: F1–F8 repaired without waiver.
- Authorization review revision 2: F9–F13 repaired without waiver:
  order-invariant quorum matching; fresh BUILD baseline; the bounded untracked
  assessment exception; exact doctor-note gate; separate C1b.
- C1b:
  `d3bb1ccce340d2a102064d57cee6136147ee5c0d`, exactly the same three
  authorization paths, independently `REVIEW_PASS`, rehearsed and pushed;
  `HEAD == origin/main` at the time of its push.
- C1b rehearsal: full suite `306 passed`; repository validator,
  `check_session_state.py`, `generate_catalog.py --check`,
  `check_file_size.py`, and `git diff --check` PASS.
- Doctor: `RESULT: PASS WITH NOTE (24 passed, 1 warning(s))`; 24 checks PASS,
  zero FAIL, sole warning
  `LEGACY_PROJECT: governed downstream catalog kit not present`.
- G1c: independent re-review of pushed C1b = `REVIEW_PASS`.
- G3: **PASS**. Codex explicitly approves the amended WORK_ORDER intact under
  the operator-delegated approval authority granted on 2026-07-26.

## C2 boundary

C2 may change exactly:

1. `SESSION/ACTIVE_SESSION_STATE.json`
2. `SESSION/SESSION_MEMORY.md`
3. `CVF_SESSION/ACTIVE_SESSION_STATE.json`
4. this handoff

No implementation, source, test, migration, catalog, roadmap, implementation
status, policy, provider-receipt, ADR, SPEC, or WORK_ORDER path belongs in C2.

## Mandatory G6 before the first BUILD edit

After C2 is committed and pushed, Claude must rehydrate the current canonical
state, this handoff, ADR, SPEC and WORK_ORDER, then explicitly declare the
transition to `IMPLEMENTATION_WORKER`. Before editing source, Claude must
verify and record:

1. `HEAD == origin/main` at the actual post-C2 commit.
2. No tracked modification.
3. The only permitted untracked path is
   `docs/decisions/ASSESSMENT_2026-07-23_OPERATIONS_WORKSPACE_REPOSITIONING.md`
   with SHA-256
   `168ea2c7a67a31bae50c9e4dbe78c2273a692f3a82a1074585e1bdb89b70fde2`,
   unchanged, unstaged and uncommitted.
4. Workspace doctor has 24 PASS, zero FAIL, and no warning beyond the single
   bounded legacy catalog-kit note.
5. Full suite passes with zero failures/errors; record the actual count as the
   BUILD baseline.
6. The two WORK_ORDER §3.10 audits surface no new path outside the 39-path
   ceiling.

Any mismatch is a stop condition. Do not repair or widen scope silently.

## Authorized BUILD

Claude may implement C3 only inside the 39-path ceiling in
`docs/work_orders/P2B_APPROVER_IDENTITY_RECONCILIATION_WORK_ORDER.md`.
Requirements and evidence are ADR/SPEC/WORK_ORDER authoritative, including:

- authenticated, server-derived, scope-bound approval receipts;
- durable Task creation intents and payload-digest binding;
- order-invariant bipartite/backtracking quorum matching, with AC-23
  permutation coverage;
- dual-backend atomic receipt/intent/audit behavior;
- deletion of `known-principals.yaml` as runtime authority;
- AC-01 through AC-23;
- one real Alibaba call only after genuine quorum for AC-16, zero provider
  calls for each refusal, and a sanitized tracked receipt;
- no PostgreSQL-live claim and no claim that production endpoints call a
  provider.

Claude must not stage, commit, amend, push, branch, or alter continuity during
C3. Stop conditions S1–S11 remain load-bearing.

## Return checkpoint

When implementation and its own evidence runs are complete, Claude stops with:

`READY_FOR_INDEPENDENT_BUILD_REVIEW`

The return must include the exact changed set, G6 baseline, targeted/full test
results, validator/doctor output, migration discovery result, live-evidence
outcome and sanitized receipt path, secret scan, and confirmations that
nothing was staged, committed or pushed.

No provider call or secret read occurred during authorization review, C1b, or
C2. The live provider call is mandatory later in C3/REVIEW under AC-16.
